IN Brief:
- The £65m Lynfield Mount redevelopment has secured full business case approval.
- The scheme combines a new two-storey ward block with refurbishment of the existing hospital.
- The project highlights the continued use of off-site delivery in complex healthcare settings.
McAvoy is set to move ahead with the £65m redevelopment of Lynfield Mount Hospital in Bradford after the scheme secured full business case approval, clearing the way for the construction phase of a long-planned overhaul of the mental health facility. The project centres on the redevelopment of the hospital’s central block and will combine refurbishment works with a new two-storey ward building, alongside external improvements intended to support recovery, safety, and day-to-day clinical operations.
The approved scheme will upgrade two existing wards to provide 100% en-suite accommodation and deliver new inpatient, clinical, and therapeutic spaces within a broader phased programme that is expected to run through to 2028. Work to prepare the site is already underway, with the next phase expected to move into the new-build and central-building refurbishment stage from spring 2026. Importantly, hospital services are expected to continue throughout the programme, which places a premium on sequencing, access planning, temporary arrangements, and the kind of delivery discipline healthcare projects demand when construction takes place on a live operational site.
Therese Patten, chief executive of Bradford District Care NHS Foundation Trust, described the approval as “an important milestone” for the Trust and said the redevelopment would bring significant improvements for service users and staff. The scheme has been developed with staff, patients, families, carers, and partner organisations, and that collaborative process shows in the brief. The design places strong emphasis on natural light, outdoor space, calmer layouts, and a more legible internal environment, reflecting the extent to which healthcare construction now has to respond to operational performance and wellbeing at the same time.
For McAvoy, the project also reinforces the position of off-site manufacturing in health-sector delivery. The company’s role as the lead off-site specialist is not incidental. In hospital settings, where programme certainty, disruption control, and buildability under constrained conditions can be as important as headline capital cost, off-site methods continue to offer a strong proposition. That does not remove complexity from the project. Live-site logistics, utility tie-ins, clinical adjacency, phased occupation, and the integration of new and existing buildings still require close coordination. But it does tilt the construction strategy towards earlier design resolution and more controlled production.
The wider industry context strengthens that point. NHS estate programmes are still under pressure from ageing buildings, backlog maintenance, workforce needs, and the continuing requirement to deliver modern environments without compromising service continuity. At the same time, the construction market remains sensitive to inflation, labour availability, and delivery risk on technically demanding public schemes. In that landscape, projects like Lynfield Mount are likely to attract attention well beyond West Yorkshire because they show how trusts are narrowing scope to fundable, buildable phases rather than waiting for wholesale estate replacement. That can produce more incremental programmes, but it also tends to bring more certainty into procurement and delivery.
The redevelopment of Lynfield Mount therefore sits at the intersection of several live themes in construction: healthcare modernisation, the continued mainstreaming of MMC and off-site manufacture, phased delivery on occupied sites, and a growing emphasis on therapeutic environments rather than purely functional accommodation. For Bradford, the scheme is a significant local project. For the wider market, it is another sign that hospital work is becoming more selective, more operationally driven, and more reliant on delivery models that can reduce uncertainty before the most disruptive site activity begins.



